What is the projected market valuation for the US gene synthesis market in 2035?

The projected market valuation for the US gene synthesis market in 2035 is $1551.5 Million. Read More

What was the overall market valuation for the US gene synthesis market in 2024?

The overall market valuation for the US gene synthesis market in 2024 was $732.25 Million. Read More

What is the expected CAGR for the US gene synthesis market during the forecast period 2025 - 2035?

The expected CAGR for the US gene synthesis market during the forecast period 2025 - 2035 is 7.06%. Read More

Which companies are considered key players in the US gene synthesis market?

Key players in the US gene synthesis market include Thermo Fisher Scientific, Integrated DNA Technologies, GenScript, Eurofins Genomics, Twist Bioscience, Synthetic Genomics, DNA2.0, Bioneer, and LGC Biosearch Technologies. Read More

What are the main application segments of the US gene synthesis market?

The main application segments of the US gene synthesis market include Synthetic Biology, Therapeutics, Vaccines, Genetic Engineering, and Agricultural Biotechnology. Read More

What is the market size for oligonucleotides in the US gene synthesis market?

The market size for oligonucleotides in the US gene synthesis market is projected to grow from $250.0 Million to $500.0 Million. Read More

How does the market for gene libraries compare to that of plasmids in the US gene synthesis market?

The market for gene libraries is expected to grow from $100.0 Million to $210.0 Million, whereas the market for plasmids is projected to increase from $200.0 Million to $400.0 Million. Read More

What technology segment is expected to have the highest market size in the US gene synthesis market?

The DNA Sequencing technology segment is expected to have the highest market size, projected to grow from $250.0 Million to $500.0 Million. Read More

Which end-use segment is anticipated to dominate the US gene synthesis market?

The Biotechnology Companies end-use segment is anticipated to dominate the US gene synthesis market, with a projected growth from $219.9 Million to $460.75 Million. Read More

What is the expected growth trend for the vaccines application segment in the US gene synthesis market?

The vaccines application segment is expected to grow from $109.35 Million to $230.75 Million, indicating a robust growth trend. Read More

US Gene Synthesis Market

US Gene Synthesis Market Research Report: Size, Share, Trend Analysis By Method (Solid-phase Synthesis, Chip-based DNA Synthesis, PCR Based Enzyme Synthesis), by Services (Antibody DNA Synthesis, Viral DNA Synthesis, Others), By Applications (Protein Engineering, Vaccine Design & Development, Disease Diagnosis, Therapeutic Antibodies, Others), By End Users (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations), and by Region (North America, Europe, Asia-Pacific, Rest of the World) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

11.8%

2024 Market Size

$ 1.9 Million

2035 Market Size

$ 6.48 Million

Healthcare ● Updated April 2026 Report ID: MRFR/HC/11810-CR | Pages: 100 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Application (USD Million)
  1. 4.1.1 Synthetic Biology
  2. 4.1.2 Therapeutics
  3. 4.1.3 Vaccines
  4. 4.1.4 Genetic Engineering
  5. 4.1.5 Agricultural Biotechnology
2. 4.2 Life Sciences, BY Product Type (USD Million)
  1. 4.2.1 Gene Libraries
  2. 4.2.2 Oligonucleotides
  3. 4.2.3 Plasmids
  4. 4.2.4 Gene Fragments
3. 4.3 Life Sciences, BY Technology (USD Million)
  1. 4.3.1 Polymerase Chain Reaction
  2. 4.3.2 Microarray Technology
  3. 4.3.3 DNA Sequencing
  4. 4.3.4 Automated Synthesis
4. 4.4 Life Sciences, BY End Use (USD Million)
  1. 4.4.1 Academic Research
  2. 4.4.2 Pharmaceutical Companies
  3. 4.4.3 Biotechnology Companies
  4. 4.4.4 Contract Research Organizations
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Integrated DNA Technologies (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 GenScript (CN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Eurofins Genomics (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Twist Bioscience (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Synthetic Genomics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 DNA2.0 (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Bioneer (KR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 LGC Biosearch Technologies (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
4. 6.4 US MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY PRODUCT TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END USE, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Life Sciences Market Segmentation

Life Sciences By Application (USD Million, 2025-2035)

Synthetic Biology
Therapeutics
Vaccines
Genetic Engineering
Agricultural Biotechnology

Life Sciences By Product Type (USD Million, 2025-2035)

Gene Libraries
Oligonucleotides
Plasmids
Gene Fragments

Life Sciences By Technology (USD Million, 2025-2035)

Polymerase Chain Reaction
Microarray Technology
DNA Sequencing
Automated Synthesis

Life Sciences By End Use (USD Million, 2025-2035)

Academic Research
US Gene Synthesis Market Companies
Biotechnology Companies
Contract Research Organizations

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”